Carol Deline
Neurology with Special Qualifications in Child Neurology · Corpus Christi, TXNPI 1760441158
Payments from drug & device makers
Across 106 payments — averaging $40.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$983
- Supernus Pharmaceuticals, Inc.$436
- Sanofi$220
- Biomerieux Inc$219
- Otter Pharmaceuticals, LLC$188
- GSK$185
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,89892%
- Education$3468%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 17 | $983 |
| Supernus Pharmaceuticals, Inc. | 24 | $436 |
| Sanofi | 2 | $220 |
| Biomerieux Inc | 2 | $219 |
| Otter Pharmaceuticals, LLC | 6 | $188 |
| GSK | 2 | $185 |
| PTC Therapeutics, Inc. | 3 | $161 |
| Livanova USA, Inc. | 5 | $141 |
| AstraZeneca | 1 | $122 |
| Travere Therapeutics, Inc. | 1 | $120 |
| Rhythm Pharmaceuticals, Inc. | 1 | $112 |
| Neurelis, Inc. | 4 | $111 |
| Biomarin Pharmaceutical Inc. | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| Pharming Healthcare, Inc. | 1 | $103 |
| Ultragenyx Pharmaceutical Inc. | 1 | $100 |
| Acadia Pharmaceuticals Inc | 3 | $96 |
| UCB, Inc. | 2 | $83 |
| Immedica Pharma US, Inc. | 3 | $82 |
| Sunovion Pharmaceuticals Inc. | 2 | $76 |
| Phadia US Inc. | 1 | $74 |
| Jazz Pharmaceuticals Inc. | 2 | $62 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $58 |
| Sarepta Therapeutics, Inc. | 1 | $52 |
| Sumitomo Pharma America, Inc. | 5 | $47 |
| Zogenix Inc. | 2 | $35 |
| ITF Therapeutics LLC | 1 | $31 |
| Aquestive Therapeutics, Inc. | 2 | $29 |
| Greenwich Biosciences, Inc. | 1 | $25 |
| SK Life Science, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Nobelpharma America, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KOSELUGO$122
- BIOFIRE SPOTFIRE Respiratory (R) Panel$121
- (815) Thiola$120
- SPINRAZA$111
- EMFLAZA$106
- AJOVY$105
- JOENJA$103
- BEXSERO$101
How this compares
$4,244 in reported general payments places this provider in the 60th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Corpus Christi
- Marcos ValdezCorpus Christi$160K
- Huda ZoghbiHouston$8.3M
- Roy EltermanDallas$5.9M
- Diana CastroDenton$2.8M
- Jerry TomasovicSan Antonio$1.5M
- Mary Kay KoenigHouston$1.3M
- Davut PehlivanHouston$1M
- Michael PerryFort Worth$939K
- Charuta JoshiDallas$902K
- Timothy LotzeHouston$806K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.